Abbott

Abbott is a global healthcare company that develops innovative medical devices and health care solutions for various areas, including cardiovascular health, diabetes management, diagnostic testing, nutrition, and more.

Positive signals

Abbott has set a science-based target to reduce its absolute Scope 1 and 2 carbon emissions by 30% from a 2018 baseline by the end of 2030, aligning with global climate objectives.

Source →

Abbott implemented over 80 environmental projects at 33 sites across 10 countries in 2020 alone, contributing to significant reductions in environmental impact and over $100 million in packaging cost savings since 2010.

Source →

Abbott Laboratories Ltd. has achieved ISO 50001 Energy Management System certification, transitioned to an electric vehicle fleet, and implemented centralized waste management and LED lighting upgrades as part of its 2023 carbon reduction initiatives.

Source →

Concerns

The 2022 infant formula recall and plant closure at Abbott's Sturgis facility contributed to a nationwide baby formula shortage in the United States, raising major concerns about product safety and supply chain resilience.

HIGH

Source →

Abbott faced significant scrutiny and regulatory action in 2022 after the FDA found unsanitary conditions and contamination risks at its Sturgis, Michigan infant formula plant, leading to a large-scale product recall and temporary plant shutdown.

CRITICAL

Source →

Following the FDA investigation, Abbott agreed to a consent decree with the U.S. Department of Justice in 2022, requiring independent expert oversight and regular FDA inspections at its Sturgis plant to ensure compliance with food safety regulations.

HIGH

Source →

Abbott

Positive signals

Abbott has set a science-based target to reduce its absolute Scope 1 and 2 carbon emissions by 30% from a 2018 baseline by the end of 2030, aligning with global climate objectives.

Abbott implemented over 80 environmental projects at 33 sites across 10 countries in 2020 alone, contributing to significant reductions in environmental impact and over $100 million in packaging cost savings since 2010.

Abbott Laboratories Ltd. has achieved ISO 50001 Energy Management System certification, transitioned to an electric vehicle fleet, and implemented centralized waste management and LED lighting upgrades as part of its 2023 carbon reduction initiatives.

Concerns

The 2022 infant formula recall and plant closure at Abbott's Sturgis facility contributed to a nationwide baby formula shortage in the United States, raising major concerns about product safety and supply chain resilience.

Abbott faced significant scrutiny and regulatory action in 2022 after the FDA found unsanitary conditions and contamination risks at its Sturgis, Michigan infant formula plant, leading to a large-scale product recall and temporary plant shutdown.

Following the FDA investigation, Abbott agreed to a consent decree with the U.S. Department of Justice in 2022, requiring independent expert oversight and regular FDA inspections at its Sturgis plant to ensure compliance with food safety regulations.

Alternatives